Healthequity Income Statement (2013-2026) | HQY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Jan2023	Apr2023	Jul2023	Oct2023	Jan2024	Apr2024	Jul2024	Oct2024	Jan2025	Apr2025	Jul2025	Oct2025	Jan2026	Apr2026
Revenue & cost
Revenue (Quarter)	189.10M	179.95M	203.30M	205.68M	206.14M	216.09M	233.84M	244.43M	243.55M	249.22M	262.39M	287.60M	299.93M	300.43M	311.82M	330.84M	325.83M	322.16M	334.59M	354.64M
Cost of Revenue (Quarter)	76.88M	76.38M	97.68M	94.08M	87.89M	88.77M	99.07M	19.93M	19.12M	19.66M	99.07M	100.46M	21.52M	22.64M	354.86M	106.53M	93.24M	24.41M	-198.63M	26.83M
Gross Profit (Quarter)	112.23M	103.57M	105.61M	111.60M	118.25M	127.32M	134.77M	148.47M	151.66M	159.18M	163.32M	187.14M	204.05M	197.03M	189.04M	224.31M	232.59M	228.06M	228.15M	256.31M
Operating items
Amortization - Intangibles (Quarter)	20.29M	19.64M	23.05M	23.70M	24.18M	23.54M	23.17M	23.17M	23.17M	23.21M	23.22M	25.55M	30.98M	28.35M	27.00M	27.00M	27.00M	27.00M	26.95M	26.52M
Research & Development (Quarter)	37.90M	38.07M	45.93M	45.18M	46.58M	48.89M	52.72M	53.19M	54.77M	55.61M	55.24M	56.09M	58.58M	60.19M	64.65M	61.44M	64.80M	65.92M	70.35M	67.77M
Selling, General & Administrative (Quarter)	22.81M	20.00M	21.93M	23.73M	25.94M	25.13M	22.68M	25.54M	27.82M	27.15M	23.14M	38.24M	32.26M	31.79M	29.98M	25.54M	29.99M	30.88M	33.53M	31.13M
Restructuring Costs (Quarter)	16.37M	13.24M	26.38M	9.29M	7.68M	6.51M	5.11M	3.46M	2.04M	2.65M	2.28M	2.14M	1.78M	34.44M	2.18M	1.27M	1.27M	1.16M	1.32M	1.11M
Other Operating Expenses (Quarter)	36.02M	32.62M	38.62M	40.68M	40.46M	41.25M	41.05M	43.10M	42.29M	42.87M	43.78M	49.04M	52.51M	50.99M	50.09M	52.99M	46.92M	51.41M	51.87M	53.35M
Operating Expenses (Quarter)	113.10M	103.94M	132.86M	118.89M	120.66M	121.78M	121.56M	125.29M	126.92M	128.29M	124.43M	145.51M	145.12M	177.40M	146.89M	141.23M	142.98M	149.37M	157.08M	153.36M
Operating Income (Quarter)	-0.88M	-0.37M	-27.25M	-7.29M	-2.41M	5.54M	13.22M	23.18M	24.74M	30.89M	38.89M	41.63M	58.93M	19.62M	42.15M	83.08M	89.61M	78.69M	71.07M	102.95M
EBIT (Quarter)	-0.88M	-0.37M	-27.25M	-7.29M	-2.41M	5.54M	13.22M	23.18M	24.74M	30.89M	38.89M	41.63M	58.93M	19.62M	42.15M	83.08M	89.61M	78.69M	71.07M	102.95M
Non-operating items
Other Non Operating Income (Quarter)	0.34M	3.12M	-5.77M	-0.30M	0.03M	0.44M	1.10M	1.83M	2.76M	3.74M	4.47M	3.40M	3.11M	4.75M	3.07M	2.73M	3.39M	2.89M	3.10M	2.05M
Non Operating Income (Quarter)	-6.91M	-8.76M	-16.52M	-10.76M	-11.46M	-11.72M	-13.21M	1.83M	2.76M	3.74M	-9.17M	-8.39M	3.11M	4.75M	48.45M	-12.12M	3.39M	-11.16M	3.10M	-10.54M
Net income details
EBT (Quarter)	-7.79M	-9.12M	-43.77M	-18.05M	-13.87M	-6.18M	0.01M	10.01M	14.22M	21.09M	29.72M	33.24M	46.62M	6.22M	29.96M	70.95M	78.05M	67.53M	60.90M	92.41M
Tax Provisions (Quarter)	-3.97M	-4.09M	-10.95M	-4.41M	-3.22M	-4.54M	0.22M	5.92M	3.64M	6.41M	3.35M	4.40M	10.79M	0.52M	3.60M	17.04M	18.19M	15.80M	11.16M	23.00M
Profit After Tax (Quarter)	-3.82M	-5.04M	-32.82M	-13.64M	-10.65M	-1.64M	-0.21M	4.09M	10.58M	14.67M	26.36M	28.81M	35.82M	5.70M	26.36M	53.91M	59.85M	51.69M	49.74M	69.42M
Income from Continuing Operations (Quarter)	-3.82M	-5.04M	-32.82M	-13.64M	-10.65M	-1.64M	-0.21M	4.09M	10.58M	14.67M	26.36M	28.84M	35.82M	5.70M	26.36M	53.91M	59.85M	51.73M	49.74M	69.42M
Consolidated Net Income (Quarter)	-3.82M	-5.04M	-32.82M	-13.64M	-10.65M	-1.64M	-0.21M	4.09M	10.58M	14.67M	26.36M	28.84M	35.82M	5.70M	26.36M	53.91M	59.85M	51.73M	49.74M	69.42M
Income towards Parent Company (Quarter)	-3.82M	-5.04M	-32.82M	-13.64M	-10.65M	-1.64M	-0.21M	4.09M	10.58M	14.67M	26.36M	28.84M	35.82M	5.70M	26.36M	53.91M	59.85M	51.73M	49.74M	69.42M
Net Income towards Common Stockholders (Quarter)	-3.82M	-5.04M	-32.82M	-13.64M	-10.65M	-1.64M	-0.21M	4.09M	10.58M	14.67M	26.36M	28.84M	35.82M	5.70M	26.36M	53.91M	59.85M	51.73M	49.74M	69.42M
Additional items
EPS (Basic) (Quarter)	-0.05	-0.06	-0.39	-0.16	-0.13	-0.02	0.00	0.05	0.12	0.17	0.31	0.33	0.41	0.07	0.30	0.62	0.69	0.60	0.58	0.82
EPS (Weighted Average and Diluted) (Quarter)	-0.05	-0.06	-0.39	-0.16	-0.13	-0.02	0.00	0.05	0.12	0.17	0.30	0.33	0.40	0.06	0.30	0.61	0.68	0.59	0.58	0.82
Shares Outstanding (Weighted Average) (Quarter)	83.48M	82.94M	83.13M	84.02M	84.44M	84.35M	84.44M	85.03M	85.29M	85.70M	85.56M	86.47M	86.81M	86.94M	86.87M	86.66M	86.55M	86.40M	86.13M	84.41M
Shares Outstanding (Diluted Average) (Quarter)	82.63M	82.94M	83.13M	84.02M	84.44M	84.35M	84.44M	86.10M	86.34M	87.12M	86.96M	88.32M	88.65M	88.70M	88.83M	88.42M	87.75M	86.97M	87.47M	85.01M
EBITDA (Quarter)	-3.82M	-5.04M	-32.82M	-13.64M	-10.65M	-1.64M	-0.21M	4.09M	10.58M	14.67M	26.36M	28.81M	35.82M	5.70M	26.36M	53.91M	89.61M	78.69M	71.07M	102.95M
Interest Expenses (Quarter)	7.25M	11.88M	10.75M	10.46M	11.49M	12.16M	14.30M	15.00M	13.27M	13.54M	13.64M	11.79M	15.43M	18.16M	15.26M	14.86M	14.96M	14.05M	13.27M	12.59M
Tax Rate (Quarter)	50.96%	44.79%	25.01%	24.44%	23.20%	73.45%	2,712.50%	59.11%	25.61%	30.42%	11.28%	13.24%	23.16%	8.28%	12.00%	24.01%	23.31%	23.40%	18.32%	24.88%

Research Tools

Developers

Healthequity Income Statement (2013-2026) | HQY

Research Tools

Developers

Healthequity Income Statement (2013-2026) | HQY

Create an account

Sign In

Reset Password